BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease
BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease
Brief-mynd生命科学公司签署协议购买使用迷幻药治疗阿尔茨海默病的权利
Oct 27 (Reuters) - MYND Life Sciences Inc MYND.CD :
路透10月27日电-Mynd Life Science Inc MYND.CD:
* MYND LIFE SCIENCES SIGNS AGREEMENT TO ACQUIRE RIGHTS FOR THE USE OF PSYCHEDELICS TO TREAT ALZHEIMER'S DISEASE AND OTHER DEMENTIAS
*Mynd生命科学签署协议,获得使用迷幻剂治疗阿尔茨海默病和其他痴呆症的权利
Source text for Eikon: ID:nCNW3R7hJa Further company coverage: MYND.CD
Eikon的源文本:ID:nCNW3R7hJa进一步的公司报道:MYND.CD
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com;)